Beizray is part of the
Microtubule Inhibitors class and treats
Lung Cancer,
Skin Cancer,
Stomach Cancer and other conditions.
Microtubule inhibitors are used to treat
ovarian cancer,
breast cancer, lung cancer,
kaposi's sarcoma, and
prostate cancer. They work by stopping cancer cell growth and preventing the spread of the cells. Beizray is only available as a brand name drug.